Lynk received the green light from the FDA to begin clinical trials of its investigational oral therapy LNK01006 for MS and other diseases.

Mirla Avila and Susan Payrovi, MDs, explain MS progression, relapse vs. change, and subtle signs that matter even with a ...

This article was reviewed by Darragh O’Carroll, MD. Hormonal Brain Fog: What It Is and What to Do About It Key Takeaways: ...

Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as Lynk Pharmaceuticals), a clinical-stage innovative drug ...

Foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) currently in clinical development. Immunomodulation by intranasal foralumab represents a novel avenue for the treatment of ...

The Try Guys star, 38, opened up about his condition in a deeply emotional YouTube video, where he partnered with WalkMS to ...

Selma Blair shared a new update on her health amid her ongoing multiple sclerosis battle after revealing her diagnosis in 2018 ...

“My year of unraveling” is how a despairing Christy Morrill described nightmarish months when his immune system hijacked his brain. What’s called autoimmune encephalitis attacks the organ that makes ...

According to a new study published by researchers at Yale and the Karolinska Institutet in Sweden, some of the same molecular changes that occur in brain inflammation also happen during normal ...

Imagine a brain implant that could be placed without surgically opening a person's skull, but instead through a simple injection in the arm. Massachusetts Institute of Technology researchers are ...